Cerevel Therapeutics Rings the Closing Bell in Celebration of its IPO

Published

Cerevel Therapeutics rings the Nasdaq Closing Bell. In celebration of its IPO, Tony Coles, M.D., Chairperson of the Board of Directors & CEO, rings the Closing Bell alongside members of the Company’s team in a virtual bell ringing ceremony.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now